Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Investing

New York Times Reports on the Polydrug Overdose Crisis and the ‘Second Meth Epidemic’

by November 13, 2023
November 13, 2023
New York Times Reports on the Polydrug Overdose Crisis and the ‘Second Meth Epidemic’

Jeffrey A. Singer

Dr. Jeffrey A. Singer, MD, is a senior fellow at the Cato Institute and works in the Department of Health Policy Studies.

The New York Times today features an important article by reporter Jan Hoffman describing how what was initially perceived as an opioid‐​related overdose crisis has morphed into a “polydrug” overdose crisis, with many nonmedical drug users combining stimulants with opioids, and often becoming addicted to more than one drug, making overdose reversal and substance use disorder treatment more challenging.

Hoffman reports that the last five years have seen methamphetamine‐​related deaths triple and cocaine‐​related deaths double. She reports that people addicted to opioids are increasingly using other substances as well, including psychostimulants like methamphetamine and cocaine, but also depressants and tranquilizers like Xanax.

This report helps bring attention to a fact I’ve been writing about for years: today’s nonmedical drug users are yesterday’s pain patients who became hooked on prescription opioids and now seek them in the black market. I mentioned in this 2019 blog post that, by 2017, the Centers for Disease Control and Prevention reported that 68 percent of opioid‐​related overdose deaths were “polydrug,” i.e., toxicology reports revealed a mix of drugs in the overdose victims’ system. The New York City Department of Health reported in 2021 that almost half of all opioid‐​related overdose deaths involved cocaine, and 41 percent involved alcohol.

Hoffman’s report brings to mind a 2018 University of Pittsburgh study I frequently cite, showing the overdose death rate has been on a steady exponential growth trend since at least 1979, with different drugs in fashion and predominating among overdose deaths at different times. It also reminds me of a 2017 study by Cicero and colleagues showing, “In 2005, only 8.7% of opioid initiators started with heroin, but this sharply increased to 33.3% (p<0.001) in 2015, with no evidence of stabilization.”

Hoffman writes:

A decade or so ago, Mexican drug lords figured out how to mass produce a synthetic “super meth.” It has provoked what some researchers are calling a second meth epidemic.

Hoffman devotes a significant portion of her piece to the second meth epidemic, providing powerful stories of some of its victims.

I wrote and told members of the House Judiciary Committee’s Subcommittee on Crime and Government Surveillance last March that the iron law of prohibition—“the harder the law enforcement, the harder the drug”—means we can expect more potent and dangerous forms of drugs to continue to arise.

In the case of meth, the Combat Methamphetamine Epidemic Act, which went into effect in 2006, drove the meth trade into the hands of the Mexican drug cartels, who quickly developed more efficient ways to make more potent meth while making patients waste billions of dollars on over‐​the‐​counter oral decongestants that are no better than placebo.

Alas, until policymakers come to terms with the fact that the polydrug overdose crisis and the “second meth epidemic” are the latest manifestations of drug prohibition, the cycle of harder enforcement yielding harder drugs and new drug “epidemics” will continue.

0
FacebookTwitterGoogle +Pinterest
previous post
Ikea owner buys Brighton shopping mall, its second in the UK
next post
Jones Act Helps Sink New Jersey Offshore Wind Project

You may also like

Implications of the Commercial Real Estate Collapse for...

June 27, 2023

Recovery: A Guide to Reforming the U.S. Health...

October 16, 2023

Nearly a Third of Gen Z Favors the Government Installing...

June 1, 2023

The Pernicious Expansion of “Public Health”

June 26, 2024

New IRS Estimate of the Tax Gap

October 13, 2023

A Dollarization Reading List

October 17, 2023

North Carolina Passenger Rail Project May Cost $70...

December 15, 2023

The Good and Bad of the New Executive...

March 10, 2025

Weak Income Tax Collections Pose Challenges for Some...

August 7, 2023

Why Did the Trump Administration Defend Obamacare at...

April 25, 2025

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Trump, lawmakers react after ‘big, beautiful bill’ clears Senate hurdle

      June 29, 2025
    • How Staff Can Strengthen HIPAA Compliance and Security

      June 29, 2025
    • Lotus denies plans to close Hethel factory amid US expansion talks

      June 29, 2025
    • Top university degrees lose sway as tech employers prioritise job-ready skills

      June 29, 2025
    • Government urges supermarkets to make healthy food more appealing in bid to tackle obesity crisis

      June 29, 2025
    • Senate Republicans ram Trump’s ‘big, beautiful bill’ through key test vote

      June 29, 2025

    Categories

    • Business (8,334)
    • Investing (2,081)
    • Politics (15,854)
    • Stocks (3,177)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved